Markets:

Overview

News

Currencies

International

Treasuries

Eton Pharmaceuticals, Inc. - Common Stock (NQ:ETON)

16.88 -0.58 (-3.32%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eton Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Wells Fargo To Rally Around 20%? Here Are 10 Other Analyst Forecasts For Monday ↗

July 03, 2023

Jefferies boosted the price target for ACM Research, Inc. (NASDAQ: ACMR) from $9 to $23.4. Jefferies analyst Nick Cheng upgraded the stock from Underperform to Buy. ACM Research shares fell 2.2% to...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 28, 2023

Via Benzinga

Stocks Mixed Following Hawkish Fed Comments ↗

June 28, 2023

Stocks are mixed, as investors unpack comments from U.S. Federal Reserve Chairman Jerome Powell before the European Central Bank (ECB).

Via Talk Markets

Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 28, 2023

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market.

Via Benzinga

Recap: Eton Pharmaceuticals Q1 Earnings ↗

May 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 28, 2023

Via Benzinga

Eton Pharmaceuticals Receives Complete Response Letter (CRL) for Dehydrated Alcohol Injection

June 28, 2023

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2023 Financial Results

May 11, 2023

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Announces Commercial Availability of Betaine Anhydrous for Oral Solution, a Generic Version of Cystadane® (betaine anhydrous for oral solution)

May 10, 2023

From Eton Pharmaceuticals

Via GlobeNewswire

Looking Into Eton Pharmaceuticals's Return On Capital Employed ↗

March 17, 2023

Via Benzinga

A Preview Of Eton Pharmaceuticals's Earnings ↗

March 15, 2023

Via Benzinga

Looking Into Eton Pharmaceuticals's Return On Capital Employed ↗

December 20, 2022

Via Benzinga

Eton Pharmaceuticals to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

May 03, 2023

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results

March 16, 2023

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600

March 15, 2023

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals to Report Fourth Quarter 2022 Financial Results on Thursday, March 16, 2023

March 07, 2023

From Eton Pharmaceuticals

Via GlobeNewswire

Recap: Eton Pharmaceuticals Q2 Earnings ↗

August 11, 2022

Eton Pharmaceuticals (NASDAQ:ETON) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Eton Pharmaceuticals Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection

January 11, 2023

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2022 Financial Results

November 10, 2022

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2022 Financial Results on Thursday, November 10, 2022

November 02, 2022

From Eton Pharmaceuticals

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 27, 2022

Gainers

Via Benzinga

Eton Pharmaceuticals to Present at the LD Micro Main Event XV Conference

October 18, 2022

From Eton Pharmaceuticals

Via GlobeNewswire

Eton Pharmaceuticals, GeoVax Labs And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗

September 26, 2022

The Nasdaq Composite dropped by around 200 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...

Via Benzinga

Looking Into Eton Pharmaceuticals's Return On Capital Employed ↗

September 07, 2022

According to data from Benzinga Pro, during Q2, Eton Pharmaceuticals's (NASDAQ:ETON) reported sales totaled $7.36 million. Despite a 70.77% increase in earnings, the company posted a loss of $1.56...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 17, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

August 18, 2022

During Thursday's trading, 62 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 19, 2022

Via Benzinga

Recap of Monday's Biotech Catalysts - End of the Day Summary ↗

July 18, 2022

Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...

Via Benzinga

Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday ↗

July 19, 2022

Gainers AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share.

Via Benzinga

Tesla, Coinbase Global And 41 Stocks Moving In Monday's Mid-Day Session ↗

July 18, 2022

Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) shares jumped 90.2% to $4.2792 after declining 11% on Friday. The company reported closing of $20.24 million initial public offering.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.